Engineering of insulin receptor isoform-selective insulin analogues.
Engineering of insulin receptor isoform-selective insulin analogues.
复制标题
DOI:
10.1371/journal.pone.0020288
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Kjeldsen T
中科院分区:
文献类型:
--
作者:
Glendorf T;Stidsen CE;Norrman M;Nishimura E;Sørensen AR;Kjeldsen T
The insulin receptor (IR) exists in two isoforms, A and B, and the isoform expression pattern is tissue-specific. The C-terminus of the insulin B chain is important for receptor binding and has been shown to contact the IR just adjacent to the region where the A and B isoforms differ. The aim of this study was to investigate the importance of the C-terminus of the B chain in IR isoform binding in order to explore the possibility of engineering tissue-specific/liver-specific insulin analogues. Insulin analogue libraries were constructed by total amino acid scanning mutagenesis. The relative binding affinities for the A and B isoform of the IR were determined by competition assays using scintillation proximity assay technology. Structural information was obtained by X-ray crystallography. Introduction of B25A or B25N mutations resulted in analogues with a 2-fold preference for the B compared to the A isoform, whereas the opposite was observed with a B25Y substitution. An acidic amino acid residue at position B27 caused an additional 2-fold selective increase in affinity for the receptor B isoform for analogues bearing a B25N mutation. Furthermore, the combination of B25H with either B27D or B27E also resulted in B isoform-preferential analogues (2-fold preference) even though the corresponding single mutation analogues displayed no differences in relative isoform binding affinity. We have discovered a new class of IR isoform-selective insulin analogues with 2–4-fold differences in relative binding affinities for either the A or the B isoform of the IR compared to human insulin. Our results demonstrate that a mutation at position B25 alone or in combination with a mutation at position B27 in the insulin molecule confers IR isoform selectivity. Isoform-preferential analogues may provide new opportunities for developing insulin analogues with improved clinical benefits.
登录
查看更多内容
影响因子:
64.8
作者:
HUA, QX;SHOELSON, SE;WEISS, MA
通讯作者:
WEISS, MA
DOI:
10.1515/bchm3.1985.366.1.521
发表时间:
1985-01-01
期刊:
BIOLOGICAL CHEMISTRY HOPPE-SEYLER
影响因子:
--
作者:
FISCHER, WH;SAUNDERS, D;ZAHN, H
通讯作者:
ZAHN, H
DOI:
10.1098/rstb.1988.0058
发表时间:
1988-07-06
影响因子:
6.3
作者:
BAKER, EN;BLUNDELL, TL;VIJAYAN, NM
通讯作者:
VIJAYAN, NM
影响因子:
2.9
作者:
KAARSHOLM, NC;NORRIS, K;HAVELUND, S
通讯作者:
HAVELUND, S
影响因子:
2.9
作者:
NAKAGAWA, SH;TAGER, HS
通讯作者:
TAGER, HS